Yahoo · Aug 14, 2026
Cryoport (CYRX) Q2 2026 Earnings Call Transcript
CGT services revenue surged 15% as clinical trial support expanded to 779 trials globally.
CY
NASDAQ · CYRX
Cryoport, Inc.
Industrials · Integrated Freight & Logistics
$17.02
Up+$0.24 (+1.43%)
Updated Sep 21, 2026, 12:12 AM
SID Score
7.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 482.65M
- P/E ratio
- 7.15
- Dividend yield
- 0.00%
- 52-week range
- $7.64 – $17.20
- Volume
- 856.8K
- Avg. volume
- 672.11K
Price performance
CYRX price history
1M range · 19 trading sessions · Daily adjusted prices
CYRX closed at $17.02 after 19 trading sessions, up 4.16% for the selected period.
- Last close
- $17.02
- Period change
- +4.16%
- Period low
- $15.14
- Period high
- $17.02
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $16.67 | $17.05 | $16.51 | $17.02 | 856.8K |
| Sep 17, 2026 | $16.80 | $17.12 | $16.55 | $16.78 | 753.47K |
| Sep 16, 2026 | $16.29 | $16.90 | $16.29 | $16.51 | 590.58K |
| Sep 15, 2026 | $15.83 | $16.43 | $15.83 | $16.31 | 688.27K |
| Sep 14, 2026 | $15.39 | $15.98 | $15.39 | $15.96 | 473.61K |
| Sep 11, 2026 | $15.46 | $15.80 | $15.39 | $15.55 | 473.83K |
| Sep 10, 2026 | $14.83 | $15.36 | $14.59 | $15.27 | 470.63K |
| Sep 9, 2026 | $15.39 | $15.695 | $15.08 | $15.14 | 531.88K |
| Sep 8, 2026 | $15.63 | $15.64 | $15.23 | $15.47 | 544.7K |
| Sep 4, 2026 | $15.65 | $15.995 | $15.49 | $15.81 | 316.81K |
| Sep 3, 2026 | $15.93 | $16.25 | $15.50 | $15.86 | 467.64K |
| Sep 2, 2026 | $15.61 | $16.16 | $15.56 | $15.78 | 420.14K |
| Sep 1, 2026 | $15.77 | $16.05 | $15.41 | $15.55 | 445.06K |
| Aug 31, 2026 | $15.92 | $16.06 | $15.77 | $16.00 | 482.51K |
| Aug 28, 2026 | $16.54 | $16.625 | $15.85 | $16.09 | 431.16K |
| Aug 27, 2026 | $16.49 | $16.905 | $16.4702 | $16.57 | 328.67K |
| Aug 26, 2026 | $16.57 | $17.08 | $16.265 | $16.57 | 267.33K |
| Aug 25, 2026 | $16.51 | $16.94 | $16.42 | $16.72 | 476.78K |
| Aug 24, 2026 | $17.00 | $17.005 | $16.10 | $16.34 | 493.27K |
Latest CYRX news
The latest Smart Investors Daily articles mentioning CYRX.
Stock researchCompany · Overview
CYRX research
Overview
Company profile and research snapshot.
Company profile
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $13.75
- Implied upside
- —
- Analysts
- 15
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 18, 2026 | BTIG | Buy | — |
| Aug 7, 2026 | Guggenheim | Buy | — |
| Aug 7, 2026 | Needham | Buy | — |
| Jul 24, 2026 | BTIG | Buy | — |
| Jun 3, 2026 | Craig-Hallum | Buy | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Aug 7, 2026
Cryoport, Inc. (CYRX) Q2 2026 Earnings Call Transcript
Cryoport, Inc. (CYRX) Q2 2026 Earnings Call August 6, 2026 5:00 PM EDTCompany ParticipantsJerrell Shelton - Chairman, President & CEORobert Stefanovich...
Benzinga · Aug 7, 2026
Guggenheim Maintains Buy on CryoPort, Raises Price Target to $16
Guggenheim analyst Subbu Nambi maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $12 to $16.
Benzinga · Aug 7, 2026
Needham Maintains Buy on CryoPort, Raises Price Target to $19
Needham analyst David Saxon maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $15 to $19.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
